CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-γ in response to p24 antigen in HIV-infected individuals: Potential contribution of anergy to HIV- specific unresponsiveness

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1685-1691

  Dybul, Mark ^a,b   Mercier, George ^b   Belson, Michael ^b   Hallahan, Claire W ^b   Liu, Shuying ^a   Perry, Cheryl ^b   Herpin, Betsey ^b   Ehler, Linda ^b   Davey, Richard T ^b   Metcalf, Julie A ^a   Mican, JoAnn M ^a   Seder, Robert A ^b   Fauci, Anthony S ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL ANERGY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0034254205     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1685     Document Type: Article

References (54)

1. Flexner, C. 1998. HIV-protease inhibitors. N. Engl. J. Med. 338:1281.
2. Autran, B., G. Carcelaint, T. S. Li, G. Gorochov, C. Blanc, M. Renaud, M. Durali, D. Mathez, V. Calvez, J. Leibowitch, et al. 1999. Restoration of the immune system with anti-retroviral therapy. Immunol. Lett. 66:207.
3. + T cell homeostasis and function in advanced HIV disease. Science 277:112.
4. Pontesilli, O., S. Kerkhof-Garde, D. W. Notermans, N. A. Foudraine, M. T. Roos, M. R. Klein, S. A. Danner, J. M. Lange, and F. Miedema. 1999. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J. Infect. Dis. 180:76.
5. Wendland, T., H. Furrer, P. L. Vernazza, K. Frutig, A. Christen, L. Matter, R. Malinverni, and W. J. Pichler. 1999. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS 13:1857.
6. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat. Med. 4:951.
7. Kroon, F. P., G. F. Rimmelzwaan, M. T. Roos, A. D. Osterhaus, D. Hamann, F. Miedema, and J. T. van Dissel. 1998. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12:F217.
8. Li, T. S., R. Tubiana, C. Katlama, V. Calvez, H. Ait Mohand, and B. Autran. 1998. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351:1682.
9. Valentine, F. T., A. Paolino, A. Saito, and R. S. Holzman. 1998. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease. AIDS Res. Hum. Retroviruses 14 (Suppl. 2):S161.
10. Kirk, O., J. D. Lundgren, C. Pedersen, H. Nielsen, and J. Gerstoft. 1999. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? AIDS 13:1647.
11. Schneider, M. M., J. C. Borleffs, R. P. Stolk, C. A. Jaspers, and A. I. Hoepelman. 1999. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet 353:201.
12. Weverling, G. J., A. Mocroft, B. Ledergerber, O. Kirk, J. Gonzales-Lahoz, A. d'Arminio Monforte, R. Proenca, A. N. Phillips, J. D. Lundgren, and P. Reiss. 1999. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection: EuroSIDA Study Group. Lancet 353:1293.
13. Jabs, D. A., S. G. Bolton, J. P. Dunn, and A. G. Palestine. 1998. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am. J. Ophthalmol. 126:817.
14. Whitcup, S. M., E. Fortin, A. S. Lindblad, P. Griffiths, J. A. Metcalf, M. R. Robinson, J. Manischewitz, B. Baird, C. Perry, I. M. Kidd, et al. 1999. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. J. Am. Med. Assoc. 282:1633.
15. Bower, M., P. Fox, K. Fife, J. Gill, M. Nelson, and B. Gazzard. 1999. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS 13:2105.
16. Chun, T. W., R. T. Davey Jr., D. Engel, H. C. Lane, and A. S. Fauci. 1999. Re-emergence of HIV after stopping therapy. Nature 401:874.
17. Garcia, F., M. Plana, C. Vidal, A. Cruceta, W. A. O'Brien, G. Pantaleo, T. Pumarola, T. Gallart, J. M. Miro, and J. M. Gatell. 1999. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 13:F79.
18. Harrigan, P. R., M. Whaley, and J. S. Montaner. 1999. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13:F59.
19. Neumann, A. U., R. Tubiana, V. Calvez, C. Robert, T. S. Li, H. Agut, B. Autran, and C. Katlama. 1999. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment: Comet Study Group. AIDS 13:677.
20. Ortiz, G. M., D. F. Nixon, A. Trkola, J. Binley, X. Jin, S. Bonhoeffer, P. J. Kuebler, S. M. Donahoe, M. A. Demoitie, W. M. Kakimoto, et al. 1999. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin. Invest. 104:R13.
21. + T cell responses associated with control of viremia. Science 278:1447.
22. Kalams, S. A., S. P. Buchbinder, E. S. Rosenberg, J. M. Billingsley, D. S. Colbert, N. G. Jones, A. K. Shea, A. K. Trocha, and B. D. Walker. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73:6715.
23. + T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy. J. Infect Dis. 180:1057.
24. Chougnet, C., E. Thomas, A. L. Landay, H. A. Kessler, S. Buchbinder, S. Scheer, and G. M. Shearer. 1998. CD40 ligand and IFN-γ synergistically restore IL-12 production in HIV-infected patients. Eur. J. Immunol. 28:646.
25. Zanussi, S., M. D'Andrea, C. Simonelli, D. Trabattoni, M. T. Bortolin, L. Caggiari, U. Tirelli, M. Clerici, and P. De Paoli. 1999. The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients. Scand. J. Immunol. 49:286.
26. + T cells in HIV infection. Clin. Exn. Immunol. 115:451.
27. Gougeon, M. L., V. Colizzi, A. Dalgleish, and L. Montagnier. 1993. New concepts in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 9:287.
28. Gougeon, M. L. 1995. Chronic activation of the immune system in HIV infection: contribution to T cell apoptosis and Vβ selective T cell anergy. Curr. Top. Microbiol. Immunol. 200:177.
29. Meyaard, L., H. Schuitemaker, and F. Miedema. 1993. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol. Today 14:161.
30. Grohmann, U., R. Bianchi, E. Ayroldi, M. L. Belladonna, D. Surace, M. C. Fioretti, and P. Puccetti. 1997. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J. Immunol. 158:3593.
31. Belladonna, M. L., U. Grohmann, R. Bianchi, E. Ayroldi, D. Surace, P. Puccetti, and M. C. Fioretti. 1998. The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. J. Chemother. 10:157.
32. Van Parijs, L., V. L. Perez, A. Biuckians, R. G. Maki, C. A. London, and A. K. Abbas. 1997. Role of interleukin 12 and costimulators in T cell anergy in vivo. J. Exp. Med. 186:1119.
33. + T cells. Immunol. Rev. 165:231.
34. Powell, J. D., J. A. Ragheb, S. Kitagawa-Sakakida, and R. H. Schwartz. 1998. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy Immunol. Rev. 165:287.
35. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV specific cell-mediated immune responses by interleuktn-12 in vitro. Science 262:1721.
36. Seder, R. A., K H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182:1067.
37. Pomesilli, O., P. Carotenuto, S. R. Kerkhof-Garde, M. T. Roos, I. P. Keet, R. A. Coutinho, J. Goudsmit, and F. Miedema. 1999. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection. AIDS Res. Hum. Retroviruses 15: 973.
38. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
39. Kiener, P. A., P. Moran-Davis, B. M. Rankin, A. F. Wahl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917.
40. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
41. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
42. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125.
43. Kuniyoshi, J. S., C. J. Kuniyoshi, A. M. Lim, F. Y. Wang, E. R. Bade, R. Lau, E. K. Thomas, and J. S. Weber. 1999. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell. Immunol. 193:48.
44. McDyer, J. F., T. J. Goletz, E. Thomas, C. H. June, and R. A. Seder. 1998. CD40 ligand/CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononuclear cells in an IL-12-and/or CD28-dependent manner. J. Immunol. 160:1701.
45. Madrenas, J., R. H. Schwartz, and R. N. Germain. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA 93:9736.
46. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317
47. Quill, H., A. Bhandoola, G. Trinchieri, J. Haluskey, and D. Peritt. 1994. Induction of interieukin 12 responsiveness is impaired in anergic T lymphocytes. J. Exp. Med. 179:1065.
48. + T cell anergy in vitro. J. Exp. Med. 187:89.
49. Andrews, C., S. L. Swain, and G. Muralidhar. 1997. CD4 T cell anergy in murine AIDS: costimulation via CD28 and the addition of IL-12 are not sufficient to rescue anergic CD4 T cells J. Immunol. 159:2132.
50. Lori, F., H. Jessen, J. Lieberman, D. Finzi, E. Rosenberg, C. Tinelli, B. Walker, R. F. Siliciano, and J. Lisziewicz. 1999. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J. Infect. Dis. 180:1827.
51. Imada, M., F. E. Simons, F. T. Jay, and K. T. Hayglass. 1995. Allergen-stimulated inlerleukin-4 and interferon-γ production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunology 85:373.
52. Surcel, H. M., M. Troye-Blomberg, S. Paulie, G. Andersson, C. Moreno, G. Pasvol, and J. Ivanyi. 1994. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171.
53. Troye-Blomberg, M., E. M. Riley, L. Kabilan, M. Holmberg, H. Perlmann, U. Andersson, C. H. Heusser, and P. Perlmann. 1990. Production by activated human T cells of intcrleukin 4 but not interferon-γ is associated with elevated levels of serum antibodies to activating malaria antigens. Proc. Natl. Acad. Sci. USA 87:5484.
54. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518.